Pilar Hernandez Jimenez | Personalized Medicine | Women Researcher Award

Pilar Hernandez Jimenez | Personalized Medicine | Women Researcher Award

Dr. Pilar Hernandez Jimenez, Hospital Universitario 12 de Octubre, Spain

Dr. María del Pilar Hernández Jiménez 🩺🔬 is a specialist in internal medicine with a focus on infectious diseases. She earned her M.D. from the Universidad de Alcalá (2011) and completed her MIR in Internal Medicine at HU 12 de Octubre (2013-2018). With expertise in HIV, tropical diseases, and antimicrobial resistance, she has contributed to multiple research projects, publishing 21 indexed articles (h-index 9). Currently, she is a Río Hortega researcher at Instituto de Salud Carlos III and a consultant at HU 12 de Octubre. Her doctoral thesis (2024) explores multidrug-resistant Pseudomonas aeruginosa.

Publication Profile

orcid

Education

Dr. Pilar Hernandez Jimenez 🎓 earned her Ph.D. in Health Sciences (2024) from Universidad Complutense de Madrid. She holds a Master’s in Infectious Diseases in Immunocompromised Patients 🦠 and has pursued multiple postgraduate specializations in infectious diseases, tropical medicine 🌍, and HIV 🏥. Her expertise spans critical areas of global health, focusing on combating infectious diseases and improving patient outcomes. With a strong academic foundation and extensive clinical knowledge, Dr. Hernandez Jimenez is dedicated to advancing research and medical practices in infectious disease management, contributing significantly to the field of immunocompromised patient care.

Experience

Dr. Pilar Hernandez Jimenez 🏥 currently serves at Instituto de Salud Carlos III and Hospital Universitario 12 de Octubre, where she plays a vital role in infectious disease research and hospital consultations. With extensive experience in leading studies on infectious diseases 🦠, she has contributed significantly to COVID-19 research 🦠, HIV studies 🏳️‍🌈, and infection management in immunocompromised patients 🤝. Her work bridges clinical practice and research, enhancing patient care and public health strategies. Through collaboration with top medical institutions, Dr. Hernandez Jimenez continues to make a meaningful impact on global health and infectious disease management.

International Exposure

Dr. Pilar Hernandez Jimenez 🌍 has gained extensive international exposure through Erasmus and MIR training in Spain 🇪🇸 and France 🇫🇷, enriching her expertise in infectious diseases. Her global collaborations extend to Brazil 🇧🇷, where she conducted research at Fundação de Medicina Tropical Doutor Heitor Vieira Dourado 🦠, contributing to advancements in tropical medicine and infectious disease management. These international experiences have allowed her to engage with diverse healthcare systems, collaborate with leading researchers, and enhance her medical practice on a global scale. Dr. Hernandez Jimenez continues to foster cross-border medical innovation and research excellence.

Research Focus

Dr. María del Pilar Hernández-Jiménez is a distinguished infectious disease researcher 🦠 specializing in prosthetic joint infections, multidrug-resistant bacteria, and antimicrobial treatments 💊. Her research focuses on periprosthetic infections, Pseudomonas aeruginosa, carbapenemase-producing Klebsiella pneumoniae, and infections in immunocompromised and transplant patients 🏥. She has contributed significantly to clinical microbiology, antimicrobial resistance, and infection control 📊. Dr. Hernández-Jiménez’s work extends to COVID-19-related infections and innovative treatments for latent tuberculosis in transplant recipients 🌍. Her extensive collaborations and impactful publications highlight her global influence in infectious disease research 🔬.

Publication Top Notes

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Mrs. Ana Catarina Sousa at School of Medicine and Biomedical Sciences – University of Porto (ICBAS),Portugal

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Ana Catarina Soares de Sousa’s academic journey is marked by a strong focus on the intersection of healthcare and engineering. She completed her Master’s degree in Health Services Management and Economics in 2021 at the prestigious University of Porto, one of the top academic institutions in Portugal. This degree provided her with in-depth knowledge of the economic and managerial aspects of healthcare services, a vital skill set for navigating the complexities of healthcare systems and improving service delivery.

Prior to this, she earned a Master’s degree in Integrated Master in Bioengineering in 2018 at the same university. This program combined principles of biology, medicine, and engineering, equipping her with a solid foundation in biomedical engineering—particularly crucial for her subsequent research on biomaterials and medical technologies. Her dual educational background uniquely positions her to address both the technical and systemic challenges in health services, a hallmark of her later work.

Since 2020, Ana Catarina has been pursuing a PhD in Biomedical Sciences at the Abel Salazar Institute of Biomedical Sciences (ICBAS) within the University of Porto. Her PhD program focuses on interdisciplinary research in medical and health sciences, allowing her to build on her expertise in biomaterials and tissue engineering, while contributing to innovations in medical biotechnology.

Professional Endeavors 💼

Ana Catarina’s professional journey reflects a commitment to both research and practical applications in the biomedical sciences. Throughout her career, she has participated in numerous research projects, taking on key roles both as a research fellow and a lead researcher. Since 2018, she has contributed to seven major research projects, focusing on cutting-edge biomedical technologies and solutions for healthcare challenges.

Among her significant projects are:

  • InnovaBIOMAS (2023–2026): An innovative biofabrication system for creating multi-tissue scaffolds for joint disease treatments. This project highlights her expertise in biomaterials and tissue engineering.
  • H2Cure (2021–2024): A project developing novel formulations, including honey-based gels and dressings with gelan gum and hyaluronic acid for wound care—an intersection of regenerative medicine and biotechnology.
  • PRECOGFIL (2020–2024): This initiative explores the development of pre-tensioned cog threads for transvaginal repair of compartment prolapse, showing her application of bioengineering in women’s health.
  • Bone2Move (2018–2021): Focused on 4D scaffolds for bone defect repair, it underscores her involvement in the evolution of tissue engineering techniques.

Her work has crossed the boundaries of disciplines, spanning medical technology, veterinary applications, regenerative medicine, and materials engineering.

Contributions and Research Focus 🔬

Ana Catarina’s contributions to the biomedical field have been prolific. With 30 peer-reviewed journal articles and 2 book chapters, she has established herself as a thought leader in the scientific community. Her research encompasses a range of fields, but she is particularly recognized for her work in Medical Biotechnology, with a specific emphasis on biomaterials and tissue engineering.

Some of the key areas of her research include:

  • Regenerative Medicine: Her focus on developing advanced biomaterials that can aid in tissue regeneration and healing has practical applications in orthopedics, wound care, and surgical interventions.
  • Veterinary Medicine: Her interdisciplinary approach extends into veterinary science, where she applies biomedical engineering techniques to animal health.
  • Translational Medicine: Ana Catarina is committed to bridging the gap between laboratory research and clinical applications, ensuring that her discoveries can have a real-world impact on patient care.
  • Sustainable Chemistry: She has also been involved in developing environmentally friendly materials and chemical processes for healthcare applications, contributing to sustainability in medical technology.
  • Chemistry for Health: Her work in this area includes the development of biomaterials and formulations aimed at improving health outcomes through innovative chemistry.

With 214 co-authors in her published works, she has demonstrated an impressive ability to collaborate across disciplines and with researchers from around the world.

Accolades and Recognition 🏆

Ana Catarina’s work has not gone unnoticed. She has been the recipient of one award that recognizes her contributions to the field of biomedical sciences. This accolade highlights her innovative approach to healthcare challenges and her ability to bring together diverse disciplines in pursuit of improved health outcomes.

In addition to her award, she has also been instrumental in the scientific community as an event organizer. She has successfully organized three major events, bringing together researchers, healthcare professionals, and industry experts to discuss the latest advancements in biomedical sciences and medical technologies.

Impact and Influence 🌍

Ana Catarina’s work in biomedical sciences has the potential to make a far-reaching impact on both human and animal health. By focusing on innovative biomaterials and medical biotechnology, she is contributing to the development of new treatments that could transform the way diseases are managed and treated. Her research on scaffold-based tissue regeneration and wound care formulations has implications for patients suffering from joint diseases, chronic wounds, and surgical complications.

Her work in the development of advanced biofabrication systems and pre-tensioned threads for surgical repairs also promises to improve surgical outcomes and post-surgical recovery for patients. Moreover, her focus on sustainable chemical processes ensures that her contributions are not only medically valuable but also environmentally responsible.

Legacy and Future Contributions 🌟

Looking ahead, Ana Catarina is poised to continue making groundbreaking contributions to the field of biomedical sciences. Her ongoing projects, particularly those related to biomaterials for regenerative medicine, have the potential to lead to new therapies that will benefit both human and veterinary medicine.

Her focus on translational research ensures that her work will continue to have a direct impact on clinical practices, making her a key figure in the future of medical biotechnology. As she progresses in her PhD journey and beyond, Ana Catarina Soares de Sousa is likely to leave a lasting legacy in the fields of tissue engineering and healthcare innovation.

In the years to come, her work is expected to influence not only scientific research but also the development of new medical technologies that will improve patient care and healthcare systems around the world.

🎓Publication 

Peripheral nerve injury treatments and advances: one health perspective

  • Authors   :Bruna Lopes, Patrícia Sousa, Rui Alvites, Mariana Branquinho, Ana Catarina Sousa, Carla Mendonça, Luís Miguel Atayde, Ana Lúcia Luís, Artur SP Varejão, Ana Colette Maurício
  • Journal    :International journal of molecular sciences
  • Year         :2022

Dental pulp stem cells and Bonelike® for bone regeneration in ovine model

  • Authors   : JM Campos, AC Sousa, AR Caseiro, SS Pedrosa, PO Pinto, MV Branqu
  • Journal    :Regenerative biomaterials
  • Year         :2019

Mesenchymal stem/stromal cells and their paracrine activity—immunomodulation mechanisms and how to influence the therapeutic potential

  • Authors   : Rui Alvites, Mariana Branquinho, Ana C Sousa, Bruna Lopes, Patrícia Sousa, Ana Colette Maurício
  • Journal    :Pharmaceutics
  • Year         :2022

Assessment of the environmental impacts of medical devices: a review

  • Authors   :Ana Catarina Sousa, Anabela Veiga, Ana Collete Maurício, Maria Ascensão Lopes, José Domingos Santos, Belmira Neto
  • Journal    :Environment, Development and Sustainability
  • Year         :2021

Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo

  • Authors   :Rui D Alvites, Mariana V Branquinho, Ana C Sousa, Irina Amorim, Rui Magalhães, Filipa João, Diogo Almeida, Sandra Amado, Justina Prada, Isabel Pires, Federica Zen, Stefania Raimondo, Ana L Luís, Stefano Geuna, Artur SP Varejão, Ana C Maurício
  • Journal    :Stem cells international
  • Year         :2021

 

Assist Prof Dr.Francesco Asnica, Personalized Medicine,Best Researcher Award

Assist Prof Dr.Francesco Asnica,Personalized Medicine ,Best Researcher Award

Assist Prof Dr.Francesco Asnica, at Department CIBIO, University of TrentDepartment CIBIO, University of Trento,Italy

Author Profile

 

Education

  • Ph.D. in Information Technology – Transdisciplinary Programme in Computational Biology (cum laude), University of Trento, Italy (May 2019)
    • Thesis: “A phylogenetic framework for large-scale analysis of microbial communities”
    • Supervisors: Prof. Enrico Blanzieri and Prof. Nicola Segata
  • Master of Science in Computer Science, University of Trento, Italy (October 2014)
    • Thesis: “PhyloPhlAn2 and GraPhlAn: novel reconstruction and visualization tools for large-scale whole-genome phylogenomics”
    • Supervisors: Prof. Enrico Blanzieri and Prof. Nicola Segata
  • Bachelor of Science in Computer Science, University of Trento, Italy (March 2012)
    • Thesis: “Installazione e Test di Estensioni Grafiche Real-time per Debian GNU/Linux”
    • Supervisor: Prof. Luca Abeni

Awards and Honors

  • Highly Cited Researcher 2023 & 2022 in Cross-Field by Clarivate™
  • Member of the Gruppo 2003 per la Ricerca Scientifica since 2023
  • Euregio Young Researcher Award 2022 (Second Place)
  • Co-recipient of the X PRÊMIO 2019 – Prêmio Octavio Frias de Oliveira
  • Doctor Darwin Prize 2017

Fellowships & Scholarships

  • Travel Grant for BITS 2018
  • Summer School Grant for the Second European Summer School on Nutrigenomics 2016
  • Travel Scholarship for ISMB/ECCB 2015

Invited Talks

Dr. Asnicar has delivered numerous invited talks at prestigious conferences and symposiums, including:

  • 9th Central European Congress of Life Sciences Eurobiotech 2024
  • 10th International Human Microbiome Consortium Congress 2024
  • IBS Days 2024
  • DF/HCC Microbiome Symposium Workshop 2024
  • 6th HCMPH Annual Symposium – Microbiome and Cancer 2024

Organized Workshops

  • Workshop on Data Standards, Interoperability, and Model Organisms in Microbiome Research (2023)
  • Workshop on Establishing Consensus for Microbiome Analysis Standards (2023)

🎓Publication Top Noted:

Paper Title : QIIME 2: reproducible, interactive, scalable, and extensible microbiome data science. PeerJ

  • Authors: Evan Bolyen, Jai Ram Rideout, Matthew R Dillon, Nicholas A Bokulich, Christian Abnet, Gabriel A Al-Ghalith, H Alexander, EJ Alm, M Arumugam, F Asnicar, Y Bai, JE Bisanz, K Bittinger, A Brejnrod, CJ Brislawn, CT Brown, BJ Callahan, AM Caraballo-Rodríguez, J Chase, JG Caporaso
  • Journal:Inc
  • Year: 2018
Paper Title : Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
    • Authors :  Francesco Asnicar, Sarah E Berry, Ana M Valdes, Long H Nguyen, Gianmarco Piccinno, David A Drew, Emily Leeming, Rachel Gibson, Caroline Le Roy, Haya Al Khatib, Lucy Francis, Mohsen Mazidi, Olatz Mompeo, Mireia Valles-Colomer, Adrian Tett, Francesco Beghini, Leonard Dubois, Davide Bazzani, Andrew Maltez Thomas, Chloe Mirzayi, Asya Khleborodova, Sehyun Oh, Rachel Hine, Christopher Bonnett, Joan Capdevila, Serge Danzanvilliers, Francesca Giordano, Ludwig Geistlinger, Levi Waldron, Richard Davies, George Hadjigeorgiou, Jonathan Wolf, José M Ordovás, Christopher Gardner, Paul W Franks, Andrew T Chan, Curtis Huttenhower, Tim D Spector, Nicola Segata
    • Journal:Nature medicine
    • Year: 2021
Paper Title :Human postprandial responses to food and potential for precision nutrition
  • Authors: Sarah E Berry, Ana M Valdes, David A Drew, Francesco Asnicar, Mohsen Mazidi, Jonathan Wolf, Joan Capdevila, George Hadjigeorgiou, Richard Davies, Haya Al Khatib, Christopher Bonnett, Sajaysurya Ganesh, Elco Bakker, Deborah Hart, Massimo Mangino, Jordi Merino, Inbar Linenberg, Patrick Wyatt, Jose M Ordovas, Christopher D Gardner, Linda M Delahanty, Andrew T Chan, Nicola Segata, Paul W Franks, Tim D Spector
  • Journal:Nature medicine
  • Year:2020
Paper Title :Strain-level microbial epidemiology and population genomics from shotgun metagenomics
  • Authors: Matthias Scholz, Doyle V Ward, Edoardo Pasolli, Thomas Tolio, Moreno Zolfo, Francesco Asnicar, Duy Tin Truong, Adrian Tett, Ardythe L Morrow, Nicola Segata
  • Journal:Nature methods
  • Year: 2016

Paper Title :Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

  • Authors: Gladys Ferrere, Maryam Tidjani Alou, Peng Liu, Anne-Gaëlle Goubet, Marine Fidelle, Oliver Kepp, Sylvère Durand, Valerio Iebba, Aurélie Fluckiger, Romain Daillère, Cassandra Thelemaque, Claudia Grajeda-Iglesias, Carolina Alves Costa Silva, Fanny Aprahamian, Déborah Lefevre, Liwei Zhao, Bernhard Ryffel, Emeline Colomba, Monica Arnedos, Damien Drubay, Conrad Rauber, Didier Raoult, Francesco Asnicar, Tim Spector, Nicola Segata, Lisa Derosa, Guido Kroemer, Laurence Zitvogel
  • Journal: JCI insight
  • Year: 2021